Diagnosing and Managing Venous Thromboembolism: What Can You Do to Improve Patient Care in Your Clinical Practice?
Released On
January 31, 2023
Expires On
January 31, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Acute Care, Emergency Medicine, Hematology-Oncology, Hospitalist, Integrative Medicine, Oncology, Primary Care, Radiology, Rheumatology
Topic(s)
Oncology
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Med Learning Group and AMEDCO.
This activity is supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance.
Credit Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit™
- Nurses — 0.5 Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended for U.S.-based oncologists, community oncologists, primary care providers, emergency medicine physicians, and allied healthcare professionals (i.e., NPs, PAs, pharmacists), VTE specialists, and/or other healthcare professionals involved in the care of patients with cancer.
Program Overview
This online enduring educational snapshot focuses on multiple topics across the spectrum of venous thromboembolism (VTE) management, including but not limited to, diagnosis, evidence-based guidelines, extended management/secondary prevention, and VTE in cancer. This program is designed specifically to address micro-learning needs of those who care for cancer patients who are at increased risk for developing VTE and cancer-associated thrombosis (CAT).
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Facilitate a timely and accurate diagnosis of VTE
- Evaluate current evidence-based guidelines for the primary treatment and secondary prevention of VTE and CAT
- Develop personalized management plans for patients with VTE and CAT
Faculty
Alok A. Khorana, MD, FACP, FASCO
Sondra and Stephen Hardis Chair in Oncology Research
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Taussig Cancer Institute and Case Comprehensive Cancer Center
Cleveland, Ohio
Physician Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing Credit Designation
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 0.5 ANCC contact hour.
Disclosures of Conflicts of Interest
- Alok A. Khorana, MD, FACP, FASCO
-
- Consulting: Bayer, Pfizer, Janssen Pharmaceuticals, Anthos Therapeutics, Parexel, Blackstone Life Sciences, and BMS
- Research grant to institution: BMS
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Sylvia Hanna, MD, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
